Intent to Sole Source - BD FACSCanto II instrument

The National Institutes of Health Clinical Center is issuing a Notice of Intent to sole‑source a service contract for its BD FACSCanto™ II flow cytometer. The contract will be awarded without competition to BD Biosciences, the instrument’s manufacturer, for preventive‑maintenance, repair, emergency on‑site service, software updates, and telephone support. Vendors may submit capability statements by the response deadline, after which the NIH will decide whether to proceed with the sole‑source award. • Service scope includes two preventive‑maintenance inspections, unlimited repair visits (Mon‑Fri), one‑business‑day emergency response, and software updates. • Contract period is one year (Nov 1 2026 – Oct 31 2027). • No monetary value is disclosed; the award will be based on BD’s capability to provide the required support.